Cargando…
Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK
BACKGROUND: Multi-cancer early detection (MCED) next-generation-sequencing blood tests represent a potential paradigm shift in screening. METHODS: We estimated the impact of screening in the US and UK. We used country-specific parameters for uptake, and test-specific sensitivity and false-positive r...
Autores principales: | Hackshaw, Allan, Cohen, Sarah S., Reichert, Heidi, Kansal, Anuraag R., Chung, Karen C., Ofman, Joshua J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575970/ https://www.ncbi.nlm.nih.gov/pubmed/34426664 http://dx.doi.org/10.1038/s41416-021-01498-4 |
Ejemplares similares
-
The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA
por: Tafazzoli, Ali, et al.
Publicado: (2022) -
Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests
por: Gelhorn, Heather, et al.
Publicado: (2022) -
Assessment of Medical and Public Assistance Expenditures and Employment Among US Adults With Cancer Diagnoses
por: Grabowski, David C., et al.
Publicado: (2023) -
Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation
por: Kansal, Anuraag R, et al.
Publicado: (2012) -
When alternatives to screening should be the priority
por: Wald, Nicholas J, et al.
Publicado: (2022)